Author Correction: Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer

Affiliations

• ¹ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.
• ² Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ³ Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
• ⁴ Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.
• ⁵ Clinical Research Department, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
• ⁶ Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
• ⁷ Dutch Breast Cancer Society, Utrecht, The Netherlands.
• ⁸ Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.
• ⁹ Department of Medical Oncology, Rijnstate Hospital, Arnhem, The Netherlands.
• ¹⁰ Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, The Netherlands.
• ¹¹ Department of Medical Oncology, Amphia, Breda, The Netherlands.
• ¹² Department of Medical Oncology, Isala Clinics, Zwolle, The Netherlands.
• ¹³ Department of Medical Oncology, St Antonius Hospital, Nieuwegein, The Netherlands.
• ¹⁴ Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Schiedam, The Netherlands.
• ¹⁵ Department of Medical Oncology, Meander Medical Center, Amersfoort, The Netherlands.
• ¹⁶ Department of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.
• ¹⁷ Department of Medical Oncology, Gelre Hospital, Apeldoorn, The Netherlands.
• ¹⁸ Department of Medical Oncology, Northwest Hospital Group, Alkmaar, The Netherlands.
• ¹⁹ Dutch Breast Cancer Research Group, BOOG Study Center, Utrecht, The Netherlands.
• ²⁰ Department of Medical Oncology, Amsterdam University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.